U.S. markets closed

Intellia Therapeutics, Inc. (NTLA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
67.74+1.26 (+1.90%)
At close: 4:00PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts14141414
Avg. Estimate-0.69-0.7-2.76-3.08
Low Estimate-0.78-0.83-3.21-4.45
High Estimate-0.54-0.55-2.16-2.3
Year Ago EPS-0.61-0.47-2.4-2.76
Revenue EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts12121414
Avg. Estimate10.12M10.91M42.51M51.69M
Low Estimate4.67M4.67M20.45M26M
High Estimate25M26M102M118M
Year Ago Sales16.26M22.22M57.99M42.51M
Sales Growth (year/est)-37.80%-50.90%-26.70%21.60%
Earnings History6/29/20209/29/202012/30/20203/30/2021
EPS Est.-0.69-0.59-0.6-0.66
EPS Actual-0.61-0.47-0.69-0.69
Difference0.080.12-0.09-0.03
Surprise %11.60%20.30%-15.00%-4.50%
EPS TrendCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.69-0.7-2.76-3.08
7 Days Ago-0.7-0.71-2.8-3.18
30 Days Ago-0.7-0.71-2.83-3.2
60 Days Ago-0.7-0.71-2.83-3.2
90 Days Ago-0.75-0.79-3.02-3.43
EPS RevisionsCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Up Last 7 Days3223
Up Last 30 Days3223
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1121
Growth EstimatesNTLAIndustrySector(s)S&P 500
Current Qtr.-13.10%N/AN/AN/A
Next Qtr.-48.90%N/AN/AN/A
Current Year-15.00%N/AN/AN/A
Next Year-11.60%N/AN/AN/A
Next 5 Years (per annum)30.00%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A